Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models

Viral Immunology

Volumn 24, Issue 4, 2011, Pages 331-339

  Ferrer, María Florencia ^a,b   Del Médico Zajac, María Paula ^b   Zanetti, Flavia Adriana ^a,b   Valera, Alejandro Rafael ^c   Zabal, Osvaldo ^b   Calamante, Gabriela ^b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^c UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHOLERA TOXIN; GLYCOPROTEIN D; HERPESVIRUS VECTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BOVINE HERPES VIRUS; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RABBIT; VIRUS EXPRESSION; VIRUS SHEDDING;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BRONCHOALVEOLAR LAVAGE FLUID; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; GENETIC VECTORS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS VACCINES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; NASAL MUCOSA; RODENT DISEASES; TIME FACTORS; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL PROTEINS; VIRUS SHEDDING;

ANIMALIA; BOVINE HERPESVIRUS 1; MUS; ORYCTOLAGUS CUNICULUS; VACCINIA VIRUS ANKARA;

EID: 80051717373     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0018     Document Type: Article

References (37)

1. Ackermann M, and Engels M: Pro and contra IBR-eradication. Vet Microbiol 2006;113:293-302. (Pubitemid 43326228)
2. Antonis AF, van der Most RG, Suezer Y, Stockhofe-Zurwieden N, Daus F, Sutter G, and Schrijver RS: Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge. Vaccine 2007;25:4818-4827. (Pubitemid 46818613)
3. Babiuk LA, L'Italien J, van Drunen Littel-van den Hurk S, Zamb T, Lawman JP, Hughes G, and Gifford GA: Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology 1987;159:57-66.
4. Babiuk LA, van Drunen Littel-van den Hurk S, and Tikoo SK: Immunology of bovine herpesvirus 1 infection. Vet Microbiol 1996;53:31-42. (Pubitemid 27013942)
5. Breathnach CC, Clark HJ, Clark RC, Olsen CW, Townsend HG, and Lunn DP: Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Vaccine 2006;24:1180-1190. (Pubitemid 43202264)
6. Carroll MW and Moss B: E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses. Biotechniques 1995;19:352-354, 356.
7. Corbett M, Bogers WM, Heeney JL, et al.: Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic. Proc Natl Acad Sci USA 2008;105:2046-2051. (Pubitemid 351439462)
8. Chase CC, Carter-Allen K, and Letchworth GJ, 3rd: The effect of bovine herpesvirus type 1 glycoproteins gI and gIII on herpesvirus infections. J Gen Virol 1989;70(Pt 6):1561-1569. (Pubitemid 19165618)
9. Chowdhury SI, Lee BJ, Mosier D, Sur JH, Osorio FA, Kennedy G, and Weiss ML: Neuropathology of bovine herpesvirus type 5 (BHV-5) meningo-encephalitis in a rabbit seizure model. J Comp Pathol 1997;117:295-310. (Pubitemid 28051082)
10. Ferrer MF, Zanetti FA, and Calamante G: [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)]. Rev Argent Microbiol 2007;39:138-142. (Pubitemid 47616107)
11. Gherardi MM, and Esteban M: Recombinant poxviruses as mucosal vaccine vectors. J Gen Virol 2005;86:2925-2936. (Pubitemid 41555556)
12. Gherardi MM, Perez-Jimenez E, Najera JL, and Esteban M: Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule. J Immunol 2004;172:6209-6220. (Pubitemid 38621227)
13. Gilbert SC, Moorthy VS, Andrews L, et al.: Synergistic DNAMVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine 2006;24:4554-4561. (Pubitemid 43776762)
14. Gomez CE, Najera JL, Domingo-Gil E, Ochoa-Callejero L, Gonzalez-Aseguinolaza G, and Esteban M: Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice. J Gen Virol 2007;88:2473-2478. (Pubitemid 47323892)
15. Guarino H, Nunez A, Repiso MV, Gil A, and Dargatz DA: Prevalence of serum antibodies to bovine herpesvirus-1 and bovine viral diarrhea virus in beef cattle in Uruguay. Prev Vet Med 2008;85:34-40.
16. Harrop R, Connolly N, Redchenko I, et al.: Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: A Phase I/II Trial. Clin Cancer Res 2006;12:3416-3424.
17. Hochstein-Mintzel V, Hanichen T, Huber HC, and Stickl H: [An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola (author's transl)]. Zentralbl Bakteriol Orig A 1975;230:283-297.
18. Khattar SK, Collins PL, and Samal SK: Immunization of cattle with recombinant Newcastle disease virus expressingbovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1. Vaccine 2010;28:3159-3170.
19. Lewis PJ, van Drunen Littel-van den H, and Babiuk LA: Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol 1999;73:10214-10223.
20. Misra V, Blumenthal RM, and Babiuk LA: Proteins specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J Virol 1981;40:367-378. (Pubitemid 12234020)
21. Odeon AC, Spath EJA, and Paloma EJ, et al.: Seroprevalencia de la diarrea viral bovina, herpesvirus bovino y virus sincicial respiratorio en Argentina. Rev Med Vet (Argentina) 2001;82:216-220.
22. OIE: Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis. In: Manual of Diagnostic Test and Vaccines for Terrestrial Animals, Chap. 2.4.13, 2008, pp. 752-767.
23. Ramirez JC, Finke D, Esteban M, Kraehenbuhl JP, and Acha- Orbea H: Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration. Arch Virol 2003;148:827-839. (Pubitemid 36567936)
24. Reed LJ, and Muench H: A simple method for estimating fifty percent endpoints. Am J Hyg 1938;27:493-497.
25. Rock DL, and Reed DE: Persistent infection with bovine herpesvirus type 1: rabbit model. Infect Immun 1982;35:371-373. (Pubitemid 12200921)
26. Rodriguez AM, Turk G, Pascutti MF, et al.: Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12-BF revealed high immune specificity with low crossreactivity against subtype B. Virus Res 2009;146:1-12.
27. Taracha EL, Bishop R, Musoke AJ, Hill AV, and Gilbert SC: Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific Tcell responses. Infect Immun 2003;71:6906-6914. (Pubitemid 37475321)
28. Tikoo SK, Campos M, and Babiuk LA: Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv Virus Res 1995;45:191-223.
29. Toussaint JF, Coen L, Letellier C, Dispas M, Gillet L, Vanderplasschen A, and Kerkhofs P: Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8. Vet Res 2005;36:529-544. (Pubitemid 40960230)
30. Valera AR, Pidone CL, Massone AR, Quiroga MA, Riganti JG, Corva SG, and Galosi CM: A simple method of infecting rabbits with Bovine herpesvirus 1 and 5. J Virol Methods 2008;150:77-79.
31. van Drunen Littel-van den H, Braun RP, Lewis PJ, et al.: Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J Gen Virol 1998;79(Pt 4):831-839. (Pubitemid 28161958)
32. van Drunen Littel-van den Hurk S, Gifford GA, and Babiuk LA: Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 1990;8:358-368.
33. van Drunen Littel-van den Hurk S, Van Donkersgoed J, Kowalski J, van den Hurk JV, Harland R, Babiuk LA, and Zamb TJ: A subunit gIV vaccine, produced by transfected mammalian cells in culture, inducesmucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 1994;12:1295-1302. (Pubitemid 24325727)
34. Wang Z, La Rosa C, Maas R, et al.: Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus. J Virol 2004;78:3965-3976. (Pubitemid 38437202)
35. Yates, W.D., 1982, A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med 46, 225-263. (Pubitemid 12027866)
36. Zamorano P, Taboga O, Dominguez M, et al.: BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice. Vaccine 2002;20:2656-2664. (Pubitemid 34600998)
37. Zhu X, and Letchworth GJ, 3rd: Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle. Vaccine 1996;14:61-69. (Pubitemid 26046544)